Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma
Anita G. Seto(Miragen Therapeutics (United States)), Aimee L. Jackson(Miragen Therapeutics (United States))
Cited by 310